1. Home
  2. AVO vs RGNX Comparison

AVO vs RGNX Comparison

Compare AVO & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$14.80

Market Cap

818.6M

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$7.89

Market Cap

761.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVO
RGNX
Founded
1983
2008
Country
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.6M
761.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AVO
RGNX
Price
$14.80
$7.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$17.00
$29.13
AVG Volume (30 Days)
880.2K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$128.55
Revenue Next Year
$0.57
$47.33
P/E Ratio
$27.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.56
$5.04
52 Week High
$14.53
$16.19

Technical Indicators

Market Signals
Indicator
AVO
RGNX
Relative Strength Index (RSI) 77.30 24.17
Support Level $13.55 $7.74
Resistance Level $14.06 $8.63
Average True Range (ATR) 0.39 0.68
MACD 0.08 -0.30
Stochastic Oscillator 98.45 4.57

Price Performance

Historical Comparison
AVO
RGNX

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: